08 Dec Lidija Marusic
Dr. Lidija Marusic is an investment manager at Innovacorp, a venture capital fund investing in seed and early-stage technology companies. With over 16 years of experience in life science technology commercialization, Lidija manages all aspects of the investment due diligence, approval and closing cycle, and works hands-on with Innovacorp’s portfolio companies.
Prior to joining Innovacorp, Lidija worked at MDS Capital Corp. (now Lumira Capital) and its seed fund MedInnova Partners, focusing on commercializing biomedical discoveries.
Lidija holds a Doctor of Medicine degree from the University of Zagreb, a PhD in molecular genetics from the International School for Advanced Studies (SISSA/ISAS) and an MBA from McMaster University. She served on the International Peer Review Panel for the Canadian Networks of Centres of Excellence (NCE) and on the Proof of Principle Peer Review Committee of the Canadian Institutes for Health Research (CIHR).
Lidija is a member of the board of directors for Appili Therapeutics, DeCell Technologies, DGI Clinical and DeNovaMed, and a board observer at ABK Biomedical and Densitas.